发明名称 |
FOXM1 PEPTIDE AND MEDICINAL AGENT COMPRISING THE SAME |
摘要 |
An objective of the present invention is to provide a means for enabling cancer immunotherapy that targets approximately 30% of various cancer patients that highly express forkhead box M1 (FOXM1) among the Japanese, by identifying FOXM1-derived peptides that can activate cancer cell-damaging human killer T cells by binding to HLA-A2. The present invention provides a peptide of (A) or (B) below:
(A) a peptide including the amino acid sequence of any one of SEQ ID NOs: 1 to 3;
(B) a peptide which includes the amino acid sequence of any one of SEQ ID NOs: 1 to 3,
wherein one, two, or several amino acid(s) are substituted, deleted, inserted, and/or added, and
wherein the peptide shows cytotoxic (killer) T cell-inducing activity. |
申请公布号 |
EP2189471(A1) |
申请公布日期 |
2010.05.26 |
申请号 |
EP20080827699 |
申请日期 |
2008.08.12 |
申请人 |
ONCOTHERAPY SCIENCE, INC. |
发明人 |
NISHIMURA, YASUHARU;YOKOMINE, KAZUNORI;TSUNODA, TAKUYA;NAKAMURA, YUSUKE |
分类号 |
C12N15/00;A61K35/14;A61K38/00;A61K39/00;A61K39/385;A61K39/395;A61P35/00;A61P43/00;C07K7/06;C07K16/44;C12N5/0783;C12P21/08 |
主分类号 |
C12N15/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|